Leap Therapeutics (LPTX) Misses Q2 EPS by 52c
Tweet
Share
E-mailGet Alerts LPTX Hot Sheet
Join SI Premium – FREE
Leap Therapeutics (NASDAQ: LPTX) reported Q2 EPS of ($0.52).
For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- Deutsche Bank Downgrades Synaptics (SYNA) to Hold
- Select Medical stockholders approve buyout by insider-led consortium
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
